tiprankstipranks
Trending News
More News >
Citius Pharma (CTXR)
:CTXR
US Market

Citius Pharmaceuticals (CTXR) Technical Analysis

Compare
1,706 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Citius Pharma’s (CTXR) Moving Averages Convergence Divergence (MACD) indicator is 0.12, suggesting Citius Pharma is a Sell.
Citius Pharma’s (CTXR) 20-Day exponential moving average is 1.05, while Citius Pharma’s (CTXR) share price is $1.53, making it a Buy.
Citius Pharma’s (CTXR) 50-Day exponential moving average is 1.06, while Citius Pharma’s (CTXR) share price is $1.53, making it a Buy.

Citius Pharmaceuticals (CTXR) Pivot Points

Jun 29, 2025, 12:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.07
1.12
1.23
1.28
1.39
1.44
1.55
Fibonacci
1.12
1.18
1.22
1.28
1.34
1.38
1.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Pharmaceuticals (CTXR) Moving Averages

Jun 29, 2025, 12:39 PM
Period
Simple
Exponential
MA5
1.28Buy
1.30Buy
MA10
1.09Buy
1.18Buy
MA20
1.01Buy
1.05Buy
MA50
0.88Buy
1.06Buy
MA100
1.29Buy
1.93Sell
MA200
4.13Sell
5.44Sell
Citius Pharma’s (CTXR) 10-Day exponential moving average is 1.18, while Citius Pharma’s (CTXR) share price is $1.53, making it a Buy.
Citius Pharma’s (CTXR) 100-Day exponential moving average is 1.93, while Citius Pharma’s (CTXR) share price is $1.53, making it a Sell.
Citius Pharma’s (CTXR) stock price is $1.53 and Citius Pharma’s (CTXR) 50-day simple moving average is 0.88, creating a Buy signal.
Citius Pharma’s (CTXR) stock price is $1.53 and Citius Pharma’s (CTXR) 100-day simple moving average is 1.29, creating a Buy signal.
Citius Pharma’s (CTXR) stock price is $1.53 and Citius Pharma’s (CTXR) 200-day simple moving average is 4.13, creating a Sell signal.

Citius Pharmaceuticals (CTXR) Technical Indicators

Jun 29, 2025, 12:39 PM
Name
Value
Implied Action
RSI (14)
68.46
Neutral
STOCH (9,6)
73.81
Neutral
STOCHRSI (14)
36.74
Neutral
MACD (12,26)
0.12
Sell
ADX (14)
49.26
Neutral
Williams %R
-52.37
Buy
CCI (14)
180.19
Sell
ATR (14)
0.23
-
Ultimate Oscillator
46.55
Neutral
ROC
80.00
Buy
Citius Pharma’s (CTXR) Relative Strength Index (RSI) is 68.46, creating a Neutral signal.
Citius Pharma’s (CTXR) Trend Strength Indicator (ADX) is 49.26, creating a Neutral signal.
Citius Pharma’s (CTXR) Commodity Channel Index (CCI) is 180.19, creating a Sell signal.
Citius Pharma’s (CTXR) Price Rate of Change (ROC) is 80.00, creating a Buy signal.

FAQ

Is CTXR a Buy, Hold, or Sell?
Based on CTXR’s technical indicators, CTXR is a Buy.
    What is CTXR’s RSI (14)?
    CTXR’s RSI (14) is 68.46, which suggests CTXR is a Neutral.
      What is CTXR’s MACD?
      CTXR’s MACD is 0.12, which suggests CTXR is a Sell.
        What is CTXR’s 5-day moving average?
        CTXR’s 5-day moving average is 1.28, which suggests CTXR is a Buy.
          What is CTXR’s 20-day moving average?
          CTXR 20-day moving average is 1.01, which suggests CTXR is a Buy.
            What is CTXR’s 50-day moving average?
            CTXR’s 50-day moving average is 0.88, which suggests CTXR is a Buy.
              What is CTXR’s 200-day moving average?
              CTXR’s 200-day moving average is 4.13, which suggests CTXR is a Sell.
                What is CTXR’s Williams % R (14)?
                CTXR’s Williams % R (14) is -52.37, which suggests CTXR is a Buy.
                  What is CTXR’s CCI (14)?
                  CTXR’s CCI (14) is 180.19, which suggests CTXR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis